Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2015, Article ID 132873, 8 pages
http://dx.doi.org/10.1155/2015/132873
Research Article

Spirulina platensis Lacks Antitumor Effect against Solid Ehrlich Carcinoma in Female Mice

1Department of Pharmacology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
2Department of Pharmacology, Faculty of Pharmacy, Tabuk University, Tabuk 71491, Saudi Arabia

Received 20 May 2015; Revised 4 August 2015; Accepted 9 August 2015

Academic Editor: Antonio Ferrer-Montiel

Copyright © 2015 Waleed Barakat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. A. Stavrovskaya, “Cellular mechanisms of multidrug resistance of tumor cells,” Biochemistry, vol. 65, no. 1, pp. 95–106, 2000. View at Google Scholar · View at Scopus
  2. C. Moorthi, R. Manavalan, and K. Kathiresan, “Nanotherapeutics to overcome conventional cancer chemotherapy limitations,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 1, pp. 67–77, 2011. View at Google Scholar · View at Scopus
  3. G. M. Cragg and D. J. Newman, “Plants as a source of anti-cancer agents,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Newman, G. M. Cragg, and K. M. Snader, “Natural products as sources of new drugs over the period 1981–2002,” Journal of Natural Products, vol. 66, no. 7, pp. 1022–1037, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Chamorro, M. Salazar, L. Favila, and H. Bourges, “Pharmacology and toxicology of Spirulina alga,” Revista de Investigación Clínica, vol. 48, no. 5, pp. 389–399, 1996. View at Google Scholar · View at Scopus
  6. J. E. Piero Estrada, P. Bermejo Bescós, and A. M. Villar del Fresno, “Antioxidant activity of different fractions of Spirulina platensis protean extract,” Farmaco, vol. 56, no. 5–7, pp. 497–500, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Romay, J. Armesto, D. Remirez, R. González, N. Ledon, and I. García, “Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae,” Inflammation Research, vol. 47, no. 1, pp. 36–41, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. B. B. Vadiraja, N. W. Gaikwad, and K. M. Madyastha, “Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats,” Biochemical and Biophysical Research Communications, vol. 249, no. 2, pp. 428–431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. K. R. Roy, K. M. Arunasree, N. P. Reddy, B. Dheeraj, G. V. Reddy, and P. Reddanna, “Alteration of mitochondrial membrane potential by Spirulina platensis C-phycocyanin induces apoptosis in the doxorubicinresistant human hepatocellular-carcinoma cell line HepG2,” Biotechnology and Applied Biochemistry, vol. 47, no. 3, pp. 159–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Mishima, J. Murata, M. Toyoshima et al., “Inhibition of tumor invasion and metastasis by calcium spirulan (Ca–SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis,” Clinical and Experimental Metastasis, vol. 16, no. 6, pp. 541–550, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Schwartz and G. Shklar, “Regression of experimental hamster cancer by beta carotene and algae extracts,” Journal of Oral and Maxillofacial Surgery, vol. 45, no. 6, pp. 510–515, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Ismail, D. A. Ali, A. Fernando et al., “Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina,” International Journal of Biological Sciences, vol. 5, no. 4, pp. 377–387, 2009. View at Google Scholar · View at Scopus
  13. M. Ozaslan, I. D. Karagoz, I. H. Kilic, and M. E. Guldur, “Ehrlich ascites carcinoma,” African Journal of Biotechnology, vol. 10, no. 13, pp. 2375–2378, 2011. View at Google Scholar · View at Scopus
  14. S. L. Da Silva, J. D. S. Chaar, and T. Yano, “Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae),” European Journal of Pharmacology, vol. 608, no. 1–3, pp. 76–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Kabel, M. N. Abdel-Rahman, A. E.-D. E. El-Sisi, M. S. Haleem, N. M. Ezzat, and M. A. El Rashidy, “Effect of atorvastatin and methotrexate on solid Ehrlich tumor,” European Journal of Pharmacology, vol. 713, no. 1–3, pp. 47–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Noaman, N. K. Badr El-Din, M. A. Bibars, A. A. Abou Mossallam, and M. Ghoneum, “Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma,” Cancer Letters, vol. 268, no. 2, pp. 348–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Chamorro-Cevallos, L. Garduño-Siciliano, B. L. Barrón, E. Madrigal-Bujaidar, D. E. Cruz-Vega, and N. Pages, “Chemoprotective effect of Spirulina (Arthrospira) against cyclophosphamide-induced mutagenicity in mice,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 567–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mandal, S. K. Jaganathan, D. Mondhe, Z. A. Wani, and H. C. Pal, “Effect of honey and eugenol on ehrlich ascites and solid carcinoma,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 989163, 5 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Sorg and B. Buckner, “A simple method of obtaining venous blood from small laboratory animals,” Proceedings of the Society for Experimental Biology and Medicine, vol. 115, pp. 1131–1132, 1964. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Fisher, J. Bryant, N. Wolmark et al., “Effect of preoperative chemotherapy on the outcome of women with operable breast cancer,” Journal of Clinical Oncology, vol. 16, no. 8, pp. 2672–2685, 1998. View at Google Scholar · View at Scopus
  21. D. Mauri, N. Pavlidis, and J. P. A. Ioannidis, “Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis,” Journal of the National Cancer Institute, vol. 97, no. 3, pp. 188–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Coseri, “Natural products and their analogues as efficient anticancer drugs,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 5, pp. 560–571, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Newman, “Natural products as leads to potential drugs: an old process or the new hope for drug discovery?” Journal of Medicinal Chemistry, vol. 51, no. 9, pp. 2589–2599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Dillon, A. P. Phuc, and J. P. Dubacq, “Nutritional value of the alga Spirulina,” World Review of Nutrition and Dietetics, vol. 77, pp. 32–46, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. V. B. Bhat and K. M. Madyastha, “C-Phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro,” Biochemical and Biophysical Research Communications, vol. 275, no. 1, pp. 20–25, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Subhashini, S. V. K. Mahipal, M. C. Reddy, M. M. Reddy, A. Rachamallu, and P. Reddanna, “Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562,” Biochemical Pharmacology, vol. 68, no. 3, pp. 453–462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. El-Moneim Mahmoud Osman, M. M. Sayed Ahmed, M. T. El-Din Khayyal, and M. M. El-Merzabani, “Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma,” Tumori, vol. 79, no. 4, pp. 268–272, 1993. View at Google Scholar · View at Scopus
  28. R. Kapoor and U. Mehta, “Utilization of β-carotene from Spirulina platensis by rats,” Plant Foods for Human Nutrition, vol. 43, no. 1, pp. 1–7, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. G. V. Mitchell, E. Grundel, M. Jenkins, and S. R. Blakely, “Effects of graded dietary levels of spirulina maxima on vitamins A and E in male rats,” Journal of Nutrition, vol. 120, no. 10, pp. 1235–1240, 1990. View at Google Scholar · View at Scopus
  30. V. Annapurna, N. Shah, P. Bhaskaram, M. S. Bamji, and V. Reddy, “Bioavailability of spirulina carotenes in preschool children,” Journal of Clinical Biochemistry and Nutrition, vol. 10, no. 2, pp. 145–151, 1991. View at Publisher · View at Google Scholar
  31. P. E. Johnson and L. E. Shubert, “Availability of iron to rats from spirulina, a blue-green alga,” Nutrition Research, vol. 6, no. 1, pp. 85–94, 1986. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Santillan, “Cultivation of the Spirulina for human consumption and for animal feed,” in Proceedings of the International Congress of Food Science and Technology, Madrid, Spain, September 1974.
  33. F. Yogianti, M. Kunisada, E. Nakano et al., “Inhibitory effects of dietary Spirulina platensis on UVB-induced skin inflammatory responses and carcinogenesis,” Journal of Investigative Dermatology, vol. 134, pp. 2610–2619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ouhtit, M. F. Ismail, A. Othman et al., “Chemoprevention of rat mammary carcinogenesis by spirulina,” The American Journal of Pathology, vol. 184, no. 1, pp. 296–303, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Trédan, C. M. Galmarini, K. Patel, and I. F. Tannock, “Drug resistance and the solid tumor microenvironment,” Journal of the National Cancer Institute, vol. 99, no. 19, pp. 1441–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Polk, M. Vaage-Nilsen, K. Vistisen, and D. L. Nielsen, “Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors,” Cancer Treatment Reviews, vol. 39, no. 8, pp. 974–984, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. W. J. Gradishar and E. E. Vokes, “5-fluorouracil cardiotoxicity: a critical review,” Annals of Oncology, vol. 1, no. 6, pp. 409–414, 1990. View at Google Scholar · View at Scopus
  38. A. A. Jakubowski and N. Kemeny, “Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil,” Cancer, vol. 62, no. 2, pp. 266–269, 1988. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Hsiao, P. O.-H. Chou, M.-Y. Shen, D.-S. Chou, C.-H. Lin, and J.-R. Sheu, “C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis,” Journal of Agricultural and Food Chemistry, vol. 53, no. 20, pp. 7734–7740, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. R. B. Diasio and B. E. Harris, “Clinical pharmacology of 5-fluorouracil,” Clinical Pharmacokinetics, vol. 16, no. 4, pp. 215–237, 1989. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Savranoglu and T. B. Tumer, “Inhibitory effects of spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions,” International Journal of Toxicology, vol. 32, no. 5, pp. 376–384, 2013. View at Publisher · View at Google Scholar · View at Scopus